Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in fireside chats at two upcoming investor conferences. Outset will participate in the Stifel 2023 Healthcare Conference on Tuesday, November 14, 2023, and the Jefferies London Healthcare Conference on Thursday, November 16, 2023.

Event: Stifel 2023 Healthcare Conference Date: Tuesday, November 14, 2023 Time: 9:45am ET

Event: Jefferies London Healthcare Conference Date: Thursday, November 16, 2022 Time: 6:30am ET / 11:30am GMT

Live and archived webcasts of the fireside chats will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Jim Mazzola Vice President, Investor Relations jmazzola@outsetmedical.com

Outset Medical (NASDAQ:OM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Outset Medical.
Outset Medical (NASDAQ:OM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Outset Medical.